AAAAAA
Results:
1-13
|
Results: 13
Authors:
Calon, F
Lavertu, N
Lemieux, AM
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bedard, PJ
Di Paolo, T
Citation: F. Calon et al., Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: Correlation with dopamine concentrations and dopamine transporter, SYNAPSE, 40(3), 2001, pp. 225-234
Authors:
Lavigne, GJ
Soucy, JP
Lobbezoo, F
Manzini, C
Blanchet, PJ
Montplaisir, JY
Citation: Gj. Lavigne et al., Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism, CLIN NEUROP, 24(3), 2001, pp. 145-149
Authors:
Calon, F
Grondin, R
Morissette, M
Goulet, M
Blanchet, PJ
Di Paolo, T
Bedard, PJ
Citation: F. Calon et al., Molecular basis of levodopa-induced dyskinesias, ANN NEUROL, 47(4), 2000, pp. S70-S78
Authors:
Calon, F
Tahar, AH
Blanchet, PJ
Morissette, M
Grondin, R
Goulet, M
Doucet, JP
Robertson, GS
Nestler, E
Di Paolo, T
Bedard, P
Citation: F. Calon et al., Dopamine-receptor stimulation: biobehavioral and biochemical consequences, TRENDS NEUR, 23(10), 2000, pp. S92-S100
Authors:
Konitsiotis, S
Blanchet, PJ
Verhagen, L
Lamers, E
Chase, TN
Citation: S. Konitsiotis et al., AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys, NEUROLOGY, 54(8), 2000, pp. 1589-1595
Authors:
Calon, F
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bedard, PJ
Di Paolo, T
Citation: F. Calon et al., I-125-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: Effect of MPTP and dopaminomimetic treatments, EXP NEUROL, 163(1), 2000, pp. 191-199
Authors:
Kato, T
Montplaisir, JY
Blanchet, PJ
Lund, JP
Lavigne, GJ
Citation: T. Kato et al., Idiopathic myoclonus in the oromandibular region during sleep: A possible source of confusion in sleep bruxism diagnosis, MOVEMENT D, 14(5), 1999, pp. 865-871
Authors:
Bedard, PJ
Blanchet, PJ
Levesque, D
Soghomonian, JJ
Grondin, R
Morissette, M
Goulet, M
Calon, F
Falardeau, P
Gomez-Mancilla, B
Doucet, JP
Robertson, GS
DiPaolo, T
Citation: Pj. Bedard et al., Pathophysiology of L-dopa-induced dyskinesias, MOVEMENT D, 14, 1999, pp. 4-8
Authors:
Blanchet, PJ
Citation: Pj. Blanchet, Rationale for use of dopamine agonists in Parkinson's disease: Review of ergot derivatives, CAN J NEUR, 26, 1999, pp. S21-S26
Authors:
Calon, F
Morissette, M
Goulet, M
Grondin, R
Blanchet, PJ
Bedard, PJ
Di Paolo, T
Citation: F. Calon et al., Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content, NEUROCHEM I, 35(1), 1999, pp. 81-91
Authors:
Blanchet, PJ
Fang, J
Hyland, K
Arnold, LA
Mouradian, MM
Chase, TN
Citation: Pj. Blanchet et al., Short-term effects of high-dose 17 beta-estradiol in postmenopausal PD patients - A crossover study, NEUROLOGY, 53(1), 1999, pp. 91-95
Authors:
Blanchet, PJ
Konitsiotis, S
Whittemore, ER
Zhou, ZL
Woodward, RM
Chase, TN
Citation: Pj. Blanchet et al., Differing effects of N-methl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys, J PHARM EXP, 290(3), 1999, pp. 1034-1040
Authors:
Blanchet, PJ
Fang, J
Gillespie, M
Sabounjian, LA
Locke, KW
Gammans, R
Mouradian, MM
Chase, TN
Citation: Pj. Blanchet et al., Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease, CLIN NEUROP, 21(6), 1998, pp. 339-343
Risultati:
1-13
|